Gelonghui November 7th | By-Health Co., Ltd. (300146.SZ) accepted specific object research on November 6, 2024, regarding the progress of the switch of the two core products and the inventory situation of the channels. The company stated that the switch between old and new products had a significant impact on the company's performance in the third quarter, and it is expected to be completed within the year. Currently, the inventory levels of the two core products in the channels have been controlled within a reasonable range.
汤臣倍健(300146.SZ):目前两大核心产品渠道库存水平已控制在合理范围内
By-Health Co., Ltd. (300146.SZ): Currently, the inventory levels of the two major core product channels have been controlled within a reasonable range.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.